Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Publicity for sports supplement programs

This article was originally published in The Tan Sheet

Executive Summary

The dietary supplement industry "is doing a horrible job" of getting information out about its self-regulatory efforts, notes Jon Benninger at the Food and Drug Law Institute's dietary supplement emerging issues and trends conference Jan. 29 in Washington. Benninger, director of business development for Virgo Publishing, recounts how the CEO of U.S. Track and Field had discouraged use of all supplements by the group's athletes and was unaware of programs that screen supplement products tailored to professional athletes. Such programs include the Athletic Banned Substances Certification Program and a separate certification initiative specifically for National Football League players, both run by NSF International (1"The Tan Sheet" Jan. 21, 2008, p. 7). While such programs are admirable, Benninger says it remains up to industry to publicize the efforts

You may also be interested in...



NSF Expands Sports Product Testing, Appoints GM At “Crucial Time”

NSF International appointed Edward Wyszumiala Jan. 14 to head the organization's supplement programs as it expands its testing of sports nutrition products for banned substances in response to growing concern about adulterated products

MDSAP And USMCA: 3 Ways Mexico Can To Come Up-To-Speed With The Single-Audit Program Targeted By New Free-Trade Accord

The US-Mexico-Canada (USMCA) treaty calls for the three countries to “recognize audits” performed under the Medical Device Single Audit Program. MDSAP is already used by device makers in the US and Canada so they can undergo one audit by an accredited third party to satisfy quality regulations. That leaves Mexico as the odd country out when it comes to using the popular program – and that means it has some catching up to do after the USMCA is ratified by all three nations. Former longtime FDA official Kim Trautman weighs in on how Mexico can incorporate MDSAP into its regulatory framework.

Execs On The Move: Major Changes At Foundation Medicine, Bardy And Lantheus

Genomic profiling firm Foundation Medicine hires new chief commercial officer; Bardy Diagnostics, developer of cardiac arrhythmia devices, picks a chief operating officer; Lantheus Medical Imaging, producer of diagnostic imaging agents and products; brings aboard a new chief medical officer; and more.

Topics

UsernamePublicRestriction

Register

PS102593

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel